Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«ELDEN

Below is an extended ELDEN news listing. Click here to return to the ELDEN main Biocorporate entry.

BioNews Results for ELDEN:

Cost cuts at Big Pharma fail to excite investors
Imaging Economics:  Oct 26 2009 8:18AM Matching: elden
Cost cuts at Big Pharma fail to excite
Clackamas Review:  Oct 26 2009 12:49AM Matching: elden
Cost cuts at Big Pharma fail to excite
Lake Oswego Review:  Oct 25 2009 7:50AM Matching: elden
Cost cuts at Big Pharma fail to excite
Exec Digital US:  Oct 25 2009 6:30AM Matching: elden
Cost cuts at Big Pharma fail to excite
Sandy Post:  Oct 23 2009 7:50AM Matching: elden
Cost cuts at Big Pharma fail to excite
Portland Tribune:  Oct 22 2009 10:58PM Matching: elden
Cost cuts at Big Pharma fail to excite
CNBC:  Oct 22 2009 8:08PM Matching: elden
Cost cuts at Big Pharma fail to excite
CNBC via MSN Money:  Oct 22 2009 6:32PM Matching: elden
Cost cuts at Big Pharma fail to excite
WFCR 88.5 FM:  Oct 22 2009 6:14PM Matching: elden
Cost cuts at Big Pharma fail to excite investors
Forbes.com:  Oct 22 2009 5:20PM Matching: elden
Cost cuts at Big Pharma fail to excite
KWMU:  Oct 22 2009 4:21PM Matching: elden
Cost cuts at Big Pharma fail to excite (Reuters)
Yahoo! News:  Oct 22 2009 4:20PM Matching: elden
Cost cuts at Big Pharma fail to excite
Reuters:  Oct 22 2009 4:12PM Matching: elden

«ELDEN

This page contained an extended ELDEN news listing. Click here to return to the ELDEN main Biocorporate entry.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.